The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
Will changes to capital gains tax affect you?
How comments about weight impact kids
Gene-editing mosquitoes to fight malaria
What makes a word truly Canadian?
Inside a boxer's brain
Hallucinations and omelettes in a 60-hour marathon
Lawsuit targets pharma giants over opioid crisis
Breaking down the 2024 federal budget
Why adults love the children’s show Bluey
Salman Rushdie on the 27 seconds that nearly ended his life
A year into Sudan’s civil war
Donald Trump faces historic criminal trial
Former Thunder Bay, Ont., police chief charged
How restorative justice can help sexual assault survivors
What comes next after Iran’s retaliation against Israel?
Alarm bells over truck driving training
Are online dietitians influenced by food industry money?
Hefty bills for not leaving hospital for long-term care
Anyone for kimchi carbonara?
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly